Review
World J Hepatol
9(5):227-241.
Published online Feb 18, 2017.
doi: 10.4254/wjh.v9.i5.227
Abstract (1065)
|
Core Tip (1025)
|
Full Article (HTML) (8271)
|
Figures (1-1) (269)
|
Tables (1-1) (249)
|
Full Article (PDF)-1022K (984)
|
Audio-1185K (31)
|
Peer-Review Report-93K (375)
|
Answering Reviewers-394K (241)
|
Received: 11/14/2016
|
Revised: 11/22/2016
|
Accepted: 12/09/2016
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (50)
|
Total Visits (17762)
|
Similar Articles (161)
|
Timeline of Article Publication (3)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(1)
|
Open
World J Hepatol
9(5):242-251.
Published online Feb 18, 2017.
doi: 10.4254/wjh.v9.i5.242
Abstract (1424)
|
Core Tip (1103)
|
Full Article (HTML) (4312)
|
Tables (1-9) (437)
|
Full Article (PDF)-848K (632)
|
Audio-1509K (17)
|
Peer-Review Report-106K (233)
|
Answering Reviewers-143K (239)
|
Received: 08/29/2016
|
Revised: 10/12/2016
|
Accepted: 12/09/2016
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (28)
|
Total Visits (12893)
|
Similar Articles (86)
|
Timeline of Article Publication (0)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
Retrospective Study
Efficacy and safety of telaprevir- and simeprevir-based triple therapies for older patients with chronic hepatitis C
World J Hepatol
9(5):252-262.
Published online Feb 18, 2017.
doi: 10.4254/wjh.v9.i5.252
Abstract (1094)
|
Core Tip (1009)
|
Full Article (HTML) (2938)
|
Figures (1-3) (243)
|
Tables (1-6) (246)
|
Full Article (PDF)-1040K (395)
|
Audio-1650K (24)
|
Peer-Review Report-138K (196)
|
Answering Reviewers-120K (157)
|
Received: 08/22/2016
|
Revised: 10/23/2016
|
Accepted: 01/14/2017
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (2)
|
Total Visits (12557)
|
Similar Articles (9)
|
Timeline of Article Publication (0)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
Observational Study
Malnutrition negatively impacts the quality of life of patients with cirrhosis: An observational study
World J Hepatol
9(5):263-269.
Published online Feb 18, 2017.
doi: 10.4254/wjh.v9.i5.263
Abstract (980)
|
Core Tip (1134)
|
Full Article (HTML) (3766)
|
Figures (1-1) (236)
|
Tables (1-3) (266)
|
Full Article (PDF)-887K (503)
|
Audio-529K (36)
|
Peer-Review Report-163K (311)
|
Answering Reviewers-193K (294)
|
Received: 08/13/2016
|
Revised: 09/12/2016
|
Accepted: 12/09/2016
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (25)
|
Total Visits (15550)
|
Similar Articles (255)
|
Timeline of Article Publication (0)
|
Authors Evaluation (1)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
Addition of simvastatin to carvedilol non responders: A new pharmacological therapy for treatment of portal hypertension
World J Hepatol
9(5):270-277.
Published online Feb 18, 2017.
doi: 10.4254/wjh.v9.i5.270
Abstract (1256)
|
Core Tip (1098)
|
Full Article (HTML) (3487)
|
Figures (1-2) (303)
|
Tables (1-3) (265)
|
Full Article (PDF)-1001K (512)
|
Audio-659K (29)
|
Peer-Review Report-111K (179)
|
Answering Reviewers-75K (188)
|
Received: 11/13/2016
|
Revised: 12/15/2016
|
Accepted: 01/14/2017
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (18)
|
Total Visits (13908)
|
Similar Articles (135)
|
Timeline of Article Publication (0)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
Systematic Reviews
Influence of vitamin D on liver fibrosis in chronic hepatitis C: A systematic review and meta-analysis of the pooled clinical trials data
World J Hepatol
9(5):278-287.
Published online Feb 18, 2017.
doi: 10.4254/wjh.v9.i5.278
Abstract (1302)
|
Core Tip (1002)
|
Full Article (HTML) (4896)
|
Figures (1-3) (480)
|
Tables (1-2) (270)
|
Full Article (PDF)-1017K (639)
|
Audio-209K (24)
|
Peer-Review Report-121K (222)
|
Answering Reviewers-168K (224)
|
Received: 11/16/2016
|
Revised: 12/14/2016
|
Accepted: 01/03/2017
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (24)
|
Total Visits (14228)
|
Similar Articles (318)
|
Timeline of Article Publication (0)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
Meta-Analysis
Is it time to rethink combined liver-kidney transplant in hepatitis C patients with advanced fibrosis?
World J Hepatol
9(5):288-292.
Published online Feb 18, 2017.
doi: 10.4254/wjh.v9.i5.288
Abstract (884)
|
Core Tip (1185)
|
Full Article (HTML) (2498)
|
Figures (1-2) (561)
|
Full Article (PDF)-825K (267)
|
Audio-1441K (16)
|
Peer-Review Report-107K (146)
|
Answering Reviewers-98K (148)
|
Received: 09/27/2016
|
Revised: 12/04/2016
|
Accepted: 12/19/2016
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (0)
|
Total Visits (9593)
|
Similar Articles (239)
|
Timeline of Article Publication (0)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open